Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NOVATO, Calif., April 19, 2024 -- Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases,...

Related Keywords

Joshua Higa ,Ultragenyx Pharmaceutical Inc ,Nasdaq ,Ultragenyx Employment Inducement Plan ,Nasdaq Listing Rule ,Markets ,